| editorial | Q871232 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJM200111223452110 |
| P698 | PubMed publication ID | 11794225 |
| P2093 | author name string | Breitner JC | |
| Zandi PP | |||
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1567-1568 | |
| P577 | publication date | 2001-11-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Do nonsteroidal antiinflammatory drugs reduce the risk of Alzheimer's disease? | |
| P478 | volume | 345 |
| Q59329999 | (+)-JQ1 attenuated LPS-induced microglial inflammation via MAPK/NFκB signaling |
| Q28195689 | A quantitative illustration of the public health potential of aspirin |
| Q89703430 | Alleviation of symptoms of Alzheimer's disease by diminishing Aβ neurotoxicity and neuroinflammation |
| Q37199294 | Better cognitive performance in elderly taking antioxidant vitamins E and C supplements in combination with nonsteroidal anti-inflammatory drugs: the Cache County Study |
| Q48417985 | Cerebrospinal fluid S100B correlates with brain atrophy in Alzheimer's disease. |
| Q77840884 | Current awareness |
| Q42368761 | Determining the Molecular Pathways Underlying the Protective Effect of Non-Steroidal Anti-Inflammatory Drugs for Alzheimer's Disease: A Bioinformatics Approach |
| Q24681261 | Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies |
| Q82029321 | Epidemiology of Parkinson's disease |
| Q36164195 | Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study |
| Q38492631 | Immune attack: the role of inflammation in Alzheimer disease. |
| Q36201574 | Immunological aetiology of major psychiatric disorders: evidence and therapeutic implications |
| Q91129691 | Implications of sleep disturbance and inflammation for Alzheimer's disease dementia |
| Q34860226 | Life course health development: an integrated framework for developing health, policy, and research |
| Q53390124 | Microglial activation is required for Abeta clearance after intracranial injection of lipopolysaccharide in APP transgenic mice. |
| Q30855129 | NADPH oxidase as a therapeutic target in Alzheimer's disease |
| Q92000951 | Neuroinflammation and Functional Connectivity in Alzheimer's Disease: Interactive Influences on Cognitive Performance |
| Q37772809 | Neuroinflammatory processes in Alzheimer's disease |
| Q24642539 | No advantage of A beta 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies |
| Q34991505 | Non-cholinergic strategies for treating and preventing Alzheimer's disease |
| Q34460952 | Non-steroidal anti-inflammatory drugs as a treatment for Alzheimer's disease: a systematic review and meta-analysis of treatment effect |
| Q28194137 | The public health potential of aspirin |
Search more.